Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.
暂无分享,去创建一个
Stephan Kopp | Wolfgang Holzer | Peter Chiba | Gerhard F Ecker | G. Ecker | P. Chiba | E. Csaszar | W. Holzer | Edina Csaszar | Brigitte Plagens | Wolfgang Ernst | S. Kopp | Wolfgang Ernst | B. Plagens
[1] L. Greenberger. Identification of drug interaction sites in P-glycoprotein. , 1998, Methods in enzymology.
[2] A. E. Senior,et al. ATPase activity of Chinese hamster P-glycoprotein. , 1998, Methods in enzymology.
[3] D. Clarke,et al. Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane* , 2000, The Journal of Biological Chemistry.
[4] A. Driessen,et al. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Clarke,et al. Cross-linking of Human Multidrug Resistance P-glycoprotein by the Substrate, Tris-(2-maleimidoethyl)amine, Is Altered by ATP Hydrolysis , 2001, The Journal of Biological Chemistry.
[6] W. Watkins,et al. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. , 2001, Journal of molecular microbiology and biotechnology.
[7] L. Mayer,et al. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] K J Schaper,et al. Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance. , 1996, Journal of medicinal chemistry.
[9] A. Goffeau,et al. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals , 1995, Current Genetics.
[10] G Ecker,et al. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance. , 1996, Molecular pharmacology.
[11] I K Pajeva,et al. Structure-activity relationships of multidrug resistance reversers. , 2001, Current medicinal chemistry.
[12] Peter R. Baker,et al. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. , 1999, Analytical chemistry.
[13] A. Safa. Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein. , 1998, Methods in enzymology.
[14] D. Clarke,et al. Mutational analysis of human P-glycoprotein. , 1998, Methods in enzymology.
[15] G Ecker,et al. Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance. , 1995, Journal of medicinal chemistry.
[16] W. T. Beck,et al. Photoaffinity substrates for P-glycoprotein. , 1992, Biochemical pharmacology.
[17] L. Joshua-Tor,et al. Essential dynamics from NMR clusters: dynamic properties of the Myb DNA-binding domain and a hinge-bending enhancing variant. , 1998, Methods.
[18] G Ecker,et al. The importance of a nitrogen atom in modulators of multidrug resistance. , 1999, Molecular pharmacology.
[19] B. Tümmler,et al. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein. , 2001, European journal of biochemistry.
[20] D. Sanglard,et al. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.
[21] G. Prestwich,et al. Using photolabile ligands in drug discovery and development. , 2000, Trends in biotechnology.
[22] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[23] K. Mechtler,et al. Characterisation of the rubber elongation factor from ammoniated latex by electrophoresis and mass spectrometry. , 2000, Journal of chromatography. A.
[24] A. Goffeau,et al. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. , 1994, The Journal of biological chemistry.
[25] P. Melera,et al. Mutations in the sixth transmembrane domain of P-glycoprotein that alter the pattern of cross-resistance also alter sensitivity to cyclosporin A reversal. , 1997, Molecular pharmacology.
[26] V. Gekeler,et al. Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers. , 1996, European journal of cancer.
[27] D. Clarke,et al. Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil* , 2001, The Journal of Biological Chemistry.
[28] J. Servos,et al. Gene SNQ2 of Saccharomyces cerevislae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases , 2004, Molecular and General Genetics MGG.
[29] K. Linton,et al. Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.
[30] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[31] I. Pastan,et al. Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding. , 1998, Methods in enzymology.
[32] A. Seelig,et al. Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[33] D. Valle,et al. Characterization and Analysis of Conserved Motifs in a Peroxisomal ATP-binding Cassette Transporter (*) , 1996, The Journal of Biological Chemistry.
[34] I. Pastan,et al. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol. , 1999, Biochemistry.
[35] G Ecker,et al. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements. , 1999, Biochemical pharmacology.
[36] G. Prestwich,et al. Benzophenone photophores in biochemistry. , 1994, Biochemistry.
[37] K. Kuchler,et al. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. , 1994, The Journal of biological chemistry.
[38] G Ecker,et al. A Combined Hansch/Free‐Wilson Approach as Predictive Tool in QSAR Studies on Propafenone‐Type Modulators of Multidrug Resistance , 1998, Archiv der Pharmazie.
[39] I. Pastan,et al. Expression of the human multidrug transporter in insect cells by a recombinant baculovirus. , 1990, Biochemistry.